← All tickers

Is AIM Worth Buying in 2026?

AIM ImmunoTech Inc.

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-08-16

Here’s whether AIM ImmunoTech Inc. (AIM) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 41 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-11.53% over 10 days); weak 1-year return of -91.4%; 3-month momentum negative (-13.1%); rising volume on a downtrend (distribution, 1.82x avg). Currently 92.6% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

AIM is trading below its 200-day MA ($0.84) — a key warning sign the longer-term trend is under pressure. An RSI of 41.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -91.4% compares to +20.4% for SPY (trailed the market by 111.8%). The current 92.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $857 today
vs. S&P 500 (SPY) — same period trailed market by 111.8%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($0.84)
✗Above 50-day MA ($0.31)
✓RSI(14) neutral zone (30–70) — currently 41.4
✗Positive return (-91.4%)
!Within 10% of period high (−92.6%)
Period Range $0.22
$0.19 $2.98
RSI (14) 41.4
0 · OversoldOverbought · 100

Key Metrics

Price$0.22
Period Return-91.4%
Period High$2.98
Period Low$0.19
Drawdown−92.6%
MA-50$0.31
MA-200$0.84
RSI (14)41.4
Avg Volume (30d)1.1M
vs. SPYtrailed by 111.8%
Return Rank#1215 of 1252

Trade AIM

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers